 Laurence Cathala
Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellum | 7 | 2021 | 224 | 1.440 |
Why?
| | Synaptic Transmission | 6 | 2021 | 289 | 1.190 |
Why?
| | Interneurons | 4 | 2025 | 122 | 1.110 |
Why?
| | Synapses | 6 | 2025 | 427 | 0.640 |
Why?
| | Substantia Nigra | 4 | 2002 | 57 | 0.510 |
Why?
| | Excitatory Postsynaptic Potentials | 5 | 2012 | 124 | 0.510 |
Why?
| | Neurons | 8 | 2010 | 1590 | 0.490 |
Why?
| | Dendrites | 5 | 2025 | 105 | 0.490 |
Why?
| | Dopamine | 3 | 2002 | 303 | 0.310 |
Why?
| | Receptors, AMPA | 4 | 2012 | 141 | 0.300 |
Why?
| | Neural Inhibition | 3 | 2025 | 169 | 0.300 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2025 | 219 | 0.260 |
Why?
| | Neocortex | 2 | 2025 | 38 | 0.250 |
Why?
| | Nerve Fibers | 3 | 2009 | 96 | 0.240 |
Why?
| | Patch-Clamp Techniques | 6 | 2012 | 286 | 0.210 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1092 | 0.200 |
Why?
| | Neurotensin | 2 | 2002 | 14 | 0.190 |
Why?
| | Norepinephrine | 2 | 2002 | 204 | 0.190 |
Why?
| | Receptors, Adrenergic, alpha-2 | 1 | 2002 | 18 | 0.190 |
Why?
| | Receptors, Glycine | 1 | 2001 | 4 | 0.180 |
Why?
| | Dihydropyridines | 1 | 2001 | 15 | 0.180 |
Why?
| | Verapamil | 1 | 2001 | 41 | 0.180 |
Why?
| | Excitatory Amino Acid Antagonists | 4 | 2012 | 100 | 0.170 |
Why?
| | Cation Transport Proteins | 1 | 2002 | 134 | 0.170 |
Why?
| | Calcium Channel Blockers | 1 | 2001 | 167 | 0.170 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2002 | 198 | 0.160 |
Why?
| | Cell Membrane | 1 | 2003 | 738 | 0.160 |
Why?
| | Protein Kinase C | 2 | 1999 | 261 | 0.160 |
Why?
| | Membrane Potentials | 5 | 2010 | 284 | 0.160 |
Why?
| | Sympathomimetics | 1 | 1999 | 21 | 0.150 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 1999 | 38 | 0.150 |
Why?
| | Spinal Cord | 1 | 2001 | 370 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 1999 | 124 | 0.140 |
Why?
| | Potassium Channels | 1 | 1999 | 151 | 0.140 |
Why?
| | Animals | 15 | 2025 | 36940 | 0.140 |
Why?
| | Models, Neurological | 4 | 2025 | 242 | 0.140 |
Why?
| | Electric Conductivity | 3 | 2005 | 86 | 0.130 |
Why?
| | Rats | 8 | 2009 | 5647 | 0.130 |
Why?
| | Synaptic Potentials | 1 | 2016 | 17 | 0.130 |
Why?
| | Mice | 7 | 2025 | 17787 | 0.130 |
Why?
| | Rats, Wistar | 3 | 2002 | 455 | 0.110 |
Why?
| | Kinetics | 3 | 2003 | 1670 | 0.100 |
Why?
| | Action Potentials | 3 | 2010 | 493 | 0.090 |
Why?
| | Receptors, GABA-A | 2 | 2002 | 142 | 0.080 |
Why?
| | Calcium | 1 | 2016 | 1199 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2012 | 156 | 0.080 |
Why?
| | Sodium Channels | 1 | 2010 | 65 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2012 | 264 | 0.080 |
Why?
| | Neuronal Plasticity | 1 | 2012 | 290 | 0.080 |
Why?
| | Benzodiazepines | 2 | 2012 | 155 | 0.080 |
Why?
| | Age Factors | 3 | 2012 | 3295 | 0.070 |
Why?
| | Staurosporine | 2 | 1999 | 20 | 0.070 |
Why?
| | Long-Term Synaptic Depression | 1 | 2009 | 56 | 0.070 |
Why?
| | Axons | 1 | 2010 | 198 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2012 | 844 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 2 | 2012 | 580 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 596 | 0.060 |
Why?
| | Kynurenic Acid | 1 | 2005 | 20 | 0.060 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 141 | 0.060 |
Why?
| | Parvalbumins | 1 | 2025 | 25 | 0.060 |
Why?
| | Somatostatin | 1 | 2025 | 61 | 0.060 |
Why?
| | Enzyme Inhibitors | 2 | 1999 | 840 | 0.060 |
Why?
| | Glutamic Acid | 1 | 2005 | 246 | 0.050 |
Why?
| | GABA Modulators | 1 | 2002 | 12 | 0.050 |
Why?
| | Furosemide | 1 | 2002 | 37 | 0.050 |
Why?
| | Temperature | 1 | 2005 | 679 | 0.050 |
Why?
| | Male | 5 | 2021 | 67762 | 0.050 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2002 | 28 | 0.050 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2002 | 36 | 0.050 |
Why?
| | Nitrendipine | 1 | 2001 | 13 | 0.050 |
Why?
| | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2001 | 11 | 0.050 |
Why?
| | Nicardipine | 1 | 2001 | 6 | 0.050 |
Why?
| | Calcium Channel Agonists | 1 | 2001 | 12 | 0.050 |
Why?
| | Nifedipine | 1 | 2001 | 29 | 0.050 |
Why?
| | Ultrasonography | 1 | 2005 | 759 | 0.050 |
Why?
| | Chloride Channels | 1 | 2001 | 35 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1738 | 0.040 |
Why?
| | Glycine | 1 | 2001 | 176 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2009 | 2486 | 0.040 |
Why?
| | Calcium Channels, L-Type | 1 | 2001 | 118 | 0.040 |
Why?
| | Magnesium | 1 | 2000 | 156 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2167 | 0.040 |
Why?
| | Drug Interactions | 1 | 2001 | 410 | 0.040 |
Why?
| | Okadaic Acid | 1 | 1999 | 14 | 0.040 |
Why?
| | Quinpirole | 1 | 1999 | 10 | 0.040 |
Why?
| | 1-Methyl-3-isobutylxanthine | 1 | 1999 | 24 | 0.040 |
Why?
| | Protein Phosphatase 1 | 1 | 1999 | 33 | 0.040 |
Why?
| | Dopamine Agonists | 1 | 1999 | 39 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1999 | 67 | 0.040 |
Why?
| | Cations | 1 | 1999 | 84 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 206 | 0.040 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 89 | 0.040 |
Why?
| | Potassium | 1 | 1999 | 147 | 0.040 |
Why?
| | Ventral Tegmental Area | 1 | 1999 | 58 | 0.040 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 136 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2002 | 553 | 0.030 |
Why?
| | Diglycerides | 1 | 1997 | 61 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2002 | 493 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 810 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1997 | 382 | 0.030 |
Why?
| | Pregnenolone Carbonitrile | 1 | 1975 | 2 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2005 | 5757 | 0.030 |
Why?
| | Female | 2 | 2021 | 73304 | 0.030 |
Why?
| | Phosphorylation | 1 | 1999 | 1759 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2001 | 4193 | 0.030 |
Why?
| | Spleen | 1 | 1975 | 514 | 0.020 |
Why?
| | Cadmium Chloride | 1 | 2012 | 4 | 0.020 |
Why?
| | Tetraethylammonium | 1 | 2012 | 16 | 0.020 |
Why?
| | Cesium | 1 | 2012 | 20 | 0.020 |
Why?
| | Sodium Channel Blockers | 1 | 2012 | 24 | 0.020 |
Why?
| | Potassium Channel Blockers | 1 | 2012 | 37 | 0.020 |
Why?
| | Tetrodotoxin | 1 | 2012 | 39 | 0.020 |
Why?
| | Glutamates | 1 | 2012 | 59 | 0.020 |
Why?
| | Biophysics | 1 | 2012 | 71 | 0.020 |
Why?
| | Peptides | 1 | 1997 | 985 | 0.020 |
Why?
| | Lasers | 1 | 2012 | 130 | 0.020 |
Why?
| | Chlorides | 1 | 2012 | 136 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 431 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 325 | 0.020 |
Why?
| | NAV1.6 Voltage-Gated Sodium Channel | 1 | 2010 | 11 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 412 | 0.020 |
Why?
| | Pyramidal Cells | 1 | 2009 | 74 | 0.020 |
Why?
| | Liver | 1 | 1975 | 1943 | 0.020 |
Why?
| | Isonicotinic Acids | 1 | 2002 | 2 | 0.010 |
Why?
| | GABA Agonists | 1 | 2002 | 19 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2010 | 3015 | 0.010 |
Why?
| | Electrophysiology | 1 | 2002 | 217 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 133 | 0.010 |
Why?
| | Motion Pictures | 1 | 1962 | 19 | 0.010 |
Why?
| | Cerebral Angiography | 1 | 1962 | 109 | 0.010 |
Why?
| | Cell Separation | 1 | 2002 | 318 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6828 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2002 | 363 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 2057 | 0.010 |
Why?
| | Splenectomy | 1 | 1975 | 62 | 0.010 |
Why?
| | Golgi Apparatus | 1 | 1975 | 100 | 0.010 |
Why?
| | Organ Size | 1 | 1975 | 477 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 1975 | 265 | 0.010 |
Why?
| | Cell Nucleus | 1 | 1975 | 620 | 0.010 |
Why?
| | Mitochondria | 1 | 1975 | 948 | 0.000 |
Why?
| | Humans | 1 | 1962 | 137585 | 0.000 |
Why?
|
|
Cathala's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|